Works in NPJ Precision Oncology, 2021, Vol 5, Issue 1
Results: 104
Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00239-3
- By:
- Publication type:
- Article
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00240-w
- By:
- Publication type:
- Article
FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00236-6
- By:
- Publication type:
- Article
Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00238-4
- By:
- Publication type:
- Article
Selective KRAS G12C inhibitors in non-small cell lung cancer: chemistry, concurrent pathway alterations, and clinical outcomes.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00237-5
- By:
- Publication type:
- Article
Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00241-9
- By:
- Publication type:
- Article
High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00242-8
- By:
- Publication type:
- Article
Pharmacogenomics characterization of the MDM2 inhibitor MI-773 reveals candidate tumours and predictive biomarkers.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00235-7
- By:
- Publication type:
- Article
An analysis of research biopsy core variability from over 5000 prospectively collected core samples.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00234-8
- By:
- Publication type:
- Article
GD2 CAR T cells against human glioblastoma.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00233-9
- By:
- Publication type:
- Article
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00230-y
- By:
- Publication type:
- Article
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00232-w
- By:
- Publication type:
- Article
Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLC.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00231-x
- By:
- Publication type:
- Article
Comprehensive RNA analysis of CSF reveals a role for CEACAM6 in lung cancer leptomeningeal metastases.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00228-6
- By:
- Publication type:
- Article
How I faced my prostate cancer: a molecular biologist's perspective.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00229-5
- By:
- Publication type:
- Article
BAP1 methylation: a prognostic marker of uveal melanoma metastasis.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00226-8
- By:
- Publication type:
- Article
Genetic mutation and biological pathway prediction based on whole slide images in breast carcinoma using deep learning.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00225-9
- By:
- Publication type:
- Article
Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00224-w
- By:
- Publication type:
- Article
Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Circulating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in Africa.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00219-7
- By:
- Publication type:
- Article
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00206-y
- By:
- Publication type:
- Article
Author Correction: Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Real-world data analyses unveiled the immune-related adverse effects of immune checkpoint inhibitors across cancer types.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00223-x
- By:
- Publication type:
- Article
Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00221-z
- By:
- Publication type:
- Article
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00206-y
- By:
- Publication type:
- Article
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00220-0
- By:
- Publication type:
- Article
Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00218-8
- By:
- Publication type:
- Article
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00211-1
- By:
- Publication type:
- Article
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00209-9
- By:
- Publication type:
- Article
Preoperative clinical and tumor genomic features associated with pathologic lymph node metastasis in clinical stage I and II lung adenocarcinoma.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00210-2
- By:
- Publication type:
- Article
Artificial intelligence for the next generation of precision oncology.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00216-w
- By:
- Publication type:
- Article
Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00215-x
- By:
- Publication type:
- Article
Quantitative MRI-based radiomics for noninvasively predicting molecular subtypes and survival in glioma patients.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00205-z
- By:
- Publication type:
- Article
Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00217-9
- By:
- Publication type:
- Article
A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00214-y
- By:
- Publication type:
- Article
Inter-eye genomic heterogeneity in bilateral retinoblastoma via aqueous humor liquid biopsy.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00212-0
- By:
- Publication type:
- Article
PERK mediates resistance to BRAF inhibition in melanoma with impaired PTEN.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00207-x
- By:
- Publication type:
- Article
Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00204-0
- By:
- Publication type:
- Article
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00203-1
- By:
- Publication type:
- Article
Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00208-w
- By:
- Publication type:
- Article
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00178-z
- By:
- Publication type:
- Article
Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00202-2
- By:
- Publication type:
- Article
Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00197-w
- By:
- Publication type:
- Article
Genetic program activity delineates risk, relapse, and therapy responsiveness in multiple myeloma.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00185-0
- By:
- Publication type:
- Article
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00192-1
- By:
- Publication type:
- Article
Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00194-z
- By:
- Publication type:
- Article
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00191-2
- By:
- Publication type:
- Article
Comprehensive molecular profiling of pulmonary pleomorphic carcinoma.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00201-3
- By:
- Publication type:
- Article
The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00200-4
- By:
- Publication type:
- Article
A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00199-8
- By:
- Publication type:
- Article